In the first open‑label study of MDMA‑assisted psychotherapy for alcohol use disorder (BIMA), 14 post‑detox participants tolerated two 187.5 mg MDMA sessions with no unexpected adverse events and showed improved psychosocial functioning. At nine months average alcohol use fell from 130.6 to 18.7 units per week, supporting safety and signalling therapeutic potential that now warrants controlled trials.
- Published
- Journal
- Journal of Psychopharmacology
- Authors
- Sessa, B., Higbed, L., Durant, C., Sakal, C., Titheradge, D., Williams, T. M., Rose-Morris, A., Brew-Girard, E., Burrows, S., Wiseman, C., Wilson, S., Rickard, J. A.